Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Questions and Answers -- Ignore unavailable to you. Want to Upgrade?

To: Don Ohland who wrote (6)	1/3/1999 3:03:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 30

You might instead consider buying something like the closed end funds HQL or HQH...they were trading at a discount last time I checked, and that would give you the diversity you are looking for (Hambrecht and Quist Life Sciences H&Q Healthcare). I found out recently that Janus was starting a Life Sciences fund too...do a word search on Janus and you'll probably hit a few messages I've posted on that recently. If you are determined to choose big cap pharma and big cap biotech, I would grab Chiron, Biogen, and American Home Products...but I don't own them. Not volatile enough for me:-) regards, Mike

To: Don Ohland who wrote (6)	1/3/1999 7:25:00 PM
From: Bert Klimer	Read Replies (1) \| Respond to of 30

One that I have been following is a small company out of Las Vegas by the name of Steroidogenesis Inhibitors. They have come down in price lately, as they are thinly traded and someone sold a bunch of 144 restricted stock once the restriction came off last month. They are in Phase II (hence all the questions on the thread) with their drug AntiCort. I don't expect them to go up in the near future, but as their clinical testing proceeds, I think they are a good candidate for an acquisition. You can visit their web-site at anticort.com Bert